NEW YORK (360Dx) – Qiagen said after the close of the market Thursday that its QuantiFeron-TB Gold test for latent tuberculosis has been selected by the Republic of Korea (South Korea) Armed Forces to screen more than 340,000 recruits in 2017.
Registering provides access to this and other free content.
Already have an account?Login Now.
This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers.
This webinar will discuss the benefits of genomically profiling the immune microenvironment of soft tissue sarcomas during neoadjuvant therapy.
This webinar will discuss how new quantitative polymerase chain reaction (qPCR) and reverse transcription qPCR (RT-qPCR) tests can accelerate the discovery and development of much-needed anti-malarial drugs and vaccines.